Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-08

Clinical Trial Update: The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis. [Phase 1, Phase 2]

View source ↗

Summary

The pharmacokinetic and pharmacodynamic study of SHR7280 tablets in premenopausal subjects with endometriosis (Phase 1/Phase 2) has completed. The trial was spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR7280

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Endometriosis | Phase 1, Phase 2 | Status: COMPLETED